Working hand-in-hand to manage pharmacy costs. Utah's innovative use of the Behavioral Pharmacy Management Program.
Explore the source record for details and available documents.
SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Management of the malignant colonic polyp remains a subject for debate even after almost two decades of experience. Some researchers believe all patients should have a colonic resection; others argue that only certain cases call for laparotomy, while still others hold for a selective approach but with varying criteria. Therefore, a survey has been made of current practice and opinion from the time colonoscopic polypectomy was introduced in 1969 to the present. The authors have reviewed a sizable segment of their experience, dividing cases of malignant polyps into two broad categories: those in which complete polypectomy was followed by bowel resection; and those undergoing polypectomy alone. The determinants leading to one course or the other were analyzed, as were the results.
A study of the speed of tumor regression in 127 uveal melanomas treated with beta-rays brachyterapy, since June 1983, allows a division into 2 groups: radiosensitive forms with a volume less than 50% in the following year, and radioresistant forms. Correlation between radio sensitivity and tumor cell type were obtained with intraoperative cytopunction, and showed the prevalence of epithelioid type. The results of enucleation indicate the prevalence of fusiform type inside the radioresistant tumor group. No precise correlation could be brought between death and the previous data, the most important negative criteria being the level of initial tumor height equal or superior to 7 mm.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.